[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Ankara Training and Research Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":150},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,5,0,[8,46,76,100,126],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":27,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100642406","flow-controlled-vs-volume-controlled-ventilation-in-morbidly-obese-patients-undergoing-laparoscopic-bariatric-surgery-100642406",false,"NCT07641829","Flow-Controlled vs Volume-Controlled Ventilation in Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery","Investigation of the Effects of Flow-Controlled Ventilation and Volume-Controlled Ventilation on Pulmonary Dynamics and Hemodynamics in Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery","Inclusion Criteria:\n\n* Age between 18 and 65 years American Society of Anesthesiologists (ASA) physical status I, II, or III Body Mass Index (BMI) ≥ 40 kg\u002Fm² Scheduled for elective laparoscopic bariatric surgery Willing to participate in the study\n\nExclusion Criteria:\n\n* ASA physical status IV or V Emergency surgical procedures Pregnant patients Patients requiring vasopressor support to maintain mean arterial pressure above 65 mmHg intraoperatively Patients with advanced pulmonary disease Patients who decline to participate in the study","ALL","18 Years",{"count":19,"type":20},34,"ESTIMATED","OBSERVATIONAL","The goal of this clinical trial is to compare the effects of flow-controlled ventilation (FCV) and volume-controlled ventilation (VCV) on hemodynamic and respiratory parameters in obese patients undergoing elective laparoscopic bariatric surgery. The main questions it aims to answer are:\n\nDoes FCV provide better intraoperative hemodynamic and respiratory stability compared to VCV during laparoscopic bariatric surgery? Is FCV a safe and feasible ventilation strategy under high intraabdominal pressure and position changes required in bariatric surgery?\n\nResearchers will compare FCV group to VCV group to see if FCV improves intraoperative respiratory mechanics and hemodynamic parameters.\n\nParticipants will:\n\nUndergo elective laparoscopic bariatric surgery with BMI \\>40 kg\u002Fm² (ASA I-III) Receive either flow-controlled or volume-controlled ventilation with individualized PEEP and tidal volume of 6-8 ml\u002Fkg predicted body weight Have intraoperative hemodynamic and respiratory parameters monitored at regular intervals, including arterial blood gas analysis Be followed postoperatively for oxygen therapy requirement and intensive care need",[24,25,26],"Obesity, Morbid","Bariatric Surgery (Sleeve Gastrectomy )","Mechanical Ventilation",[28,29,30,31,32],"Flow-controlled ventilation","Volume-controlled ventilation","Respiratory mechanics","Lung-protective ventilation","Bariatric surgery","RECRUITING","2026-06-07",{"date":36,"type":37},"2026-06-11","ACTUAL",{"date":39,"type":37},"2026-03-15",{"date":41,"type":20},"2026-08",{"name":43,"class":44},"Ankara Training and Research Hospital","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":4,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":16,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":57,"studyType":21,"phases":4,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":74,"locationsCount":75},"100622284","perineural-dextrose-versus-local-anesthetic-injections-in-knee-osteoarthritis-100622284","NCT07381621","Perineural Dextrose Versus Local Anesthetic Injections in Knee Osteoarthritis","A Prospective Evaluation of the Clinical Effectiveness of Perineural Dextrose and Conventional Local Anesthetic Injections in Patients With Symptomatic Knee Osteoarthritis","Inclusion Criteria:\n\n* Symptomatic knee osteoarthritis\n* Clinical\u002Fradiological diagnosis\n* Knee pain ≥ 3 months\n* Written informed consent\n\nExclusion Criteria:\n\n* Prior knee surgery\n* Recent intra-articular injection\n* Inflammatory rheumatic disease\n* Severe systemic or neurological disease\n* Pregnancy or breastfeeding","40 Years","65 Years",{"count":56,"type":20},86,"6 Months","This prospective observational study aims to compare the clinical effectiveness of perineural 5% dextrose injections and perineural local anesthetic injections in patients with symptomatic knee osteoarthritis. Adult patients receiving routine perineural injection therapy will be followed for six months. Pain intensity and functional outcomes will be assessed at baseline and at 1, 3, and 6 months after treatment using validated clinical assessment tools.",[60],"Knee Osteoarthritis",[62,63,64,65,66,67],"Perineural Injection","Dextrose Injection","Local Anesthetic Injection","Pain","WOMAC","Observational Study","2026-04-16",{"date":70,"type":37},"2026-04-17",{"date":72,"type":37},"2026-02-02",{"date":41,"type":20},{"name":43,"class":44},2,{"id":77,"slug":78,"hasResults":11,"nctId":79,"briefTitle":80,"officialTitle":81,"acronym":4,"eligibilityCriteria":82,"healthyVolunteers":83,"sex":16,"minAge":17,"maxAge":84,"enrollmentInfo":85,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":87,"conditions":88,"keywords":91,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":93,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},"100589704","craniovertebral-angle-and-fibromyalgia-severity-100589704","NCT06957873","Craniovertebral Angle and Fibromyalgia Severity","Evaluation of the Relationship Between Craniovertebral Angle and Fibromyalgia Symptom Severity","Inclusion Criteria:\n\n* Aged 18-55 years\n* Diagnosed with Fibromyalgia (FM) according to The American College of Rheumatology (ACR) 2010 Diagnostic Criteria for Fibromyalgia\n\nExclusion Criteria:\n\n* History of past or current pathology in the cervical spine, thoracic spine, or upper extremities\n* History of paraspinal or thoracic surgery involving the head, spine, or shoulders within the last six months\n* Structural spinal malformation\n* History of surgical or neurological disorders\n* Cervical trauma or pain treatment within the last 6 months\n* Temporomandibular surgery\n* Psychiatric disorders (e.g., dementia, amnesia, or delirium)\n* Systemic inflammatory rheumatic diseases",true,"55 Years",{"count":86,"type":20},134,"Forward Head Posture Frequency in Fibromyalgia Patients Assessed by Craniovertebral Angle: Association with Symptom Severity. Forward head posture is more common in patients with fibromyalgia and is a factor that increases symptom severity.",[89,90],"Craniovertebral Angle","Fibromyalgia Syndrome",[90,92],"craniovertebral angle",{"date":70,"type":37},{"date":95,"type":37},"2025-04-01",{"date":97,"type":20},"2026-08-01",{"name":43,"class":44},3,{"id":101,"slug":102,"hasResults":11,"nctId":103,"briefTitle":104,"officialTitle":105,"acronym":4,"eligibilityCriteria":106,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":54,"enrollmentInfo":107,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":109,"conditions":110,"keywords":114,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":118,"lastUpdatePostDateStruct":119,"startDateStruct":121,"completionDateStruct":123,"leadSponsor":125,"locationsCount":45},"100580511","ultrasonographic-analysis-of-post-traumatic-shoulder-lesions-after-hand-trauma-100580511","NCT06838247","Ultrasonographic Analysis of Post-Traumatic Shoulder Lesions After Hand Trauma","Detection of Simultaneous Presence of Shoulder Lesions in Patients With Hand Injuries by Diagnostic Ultrasonography","Inclusion Criteria:\n\n* Having a history of hand injury and applying for hand rehabilitation after surgical and conservative treatment.\n\nExclusion Criteria:\n\n* Being under 18 and over 65 years of age\n* Patients with systemic diseases (Diabetes mellitus, Peripheral vascular diseases)\n* Any rheumatic disease involving the hand and upper extremity\n* History of neuropathy involving the hand and upper extremity\n* Those with any shoulder problems prior to the hand injury\n* Those with an open wound on the hand\n* Those who cannot cooperate\n* Other upper extremity traumatic injuries occurring during the hand injury",{"count":108,"type":20},60,"The purpose of the study is to reveal whether there are concurrent shoulder lesions in patients with hand injuries. Its importance is that it will shed light on whether not only the hand but also the shoulder should be included in the treatment program in hand rehabilitation.",[111,112,113],"Shoulder","Ultrasonographic","Hand Injuries",[115,111,116,117],"Hand injuries","Diagnostic","Ultrasonography","2026-03-19",{"date":120,"type":37},"2026-03-23",{"date":122,"type":37},"2024-11-11",{"date":124,"type":20},"2026-07-01",{"name":43,"class":44},{"id":127,"slug":128,"hasResults":11,"nctId":129,"briefTitle":130,"officialTitle":130,"acronym":4,"eligibilityCriteria":131,"healthyVolunteers":11,"sex":132,"minAge":53,"maxAge":133,"enrollmentInfo":134,"targetDuration":4,"studyType":136,"phases":137,"briefSummary":139,"conditions":140,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":142,"lastUpdatePostDateStruct":143,"startDateStruct":145,"completionDateStruct":147,"leadSponsor":149,"locationsCount":45},"100582601","management-of-dysuria-and-irritative-symptoms-after-holep-a-prospective-study-evaluating-the-efficacy-of-alpha-blocker-therapy-100582601","NCT06865430","Management of Dysuria and Irritative Symptoms After HoLEP: a Prospective Study Evaluating the Efficacy of Alpha-Blocker Therapy","Inclusion Criteria:\n\nMen over 40 years old, under 85 years old, and HoLEP surgery\n\nExclusion Criteria:\n\nProstate cancer, patients with bladder stones, patients with a history of urethral stricture, patients with detrusor underactivity in urodynamics, those who have had prostate surgery before","MALE","85 Years",{"count":135,"type":20},82,"INTERVENTIONAL",[138],"NA","Holmium Laser Enucleation of the Prostate (HoLEP) is an increasingly popular endoscopic minimally invasive surgical technique for the treatment of benign prostatic hyperplasia (BPH). In the literature, the long-term efficacy and low complication rates of HoLEP have been highlighted in many studies. However, in the early postoperative period, particularly within the first three months, irritative symptoms are reported in 17-35% of cases (1-2).\n\nThe pathophysiology of postoperative irritative symptoms is not yet fully understood, but it has been suggested that these symptoms may be associated with urethral trauma, the mucosal healing process, and detrusor overactivity. These symptoms can significantly impact quality of life, reducing patient satisfaction. In particular, dysuria is a frequently encountered symptom after HoLEP, with considerable individual variability in its severity and duration.\n\nThe effectiveness of alpha-blockers in alleviating postoperative dysuria and irritative symptoms remains a topic of debate in the literature. Although prostate tissue is surgically removed, alpha-blockers may improve urinary flow and relieve symptoms associated with bladder outlet obstruction by reducing urethral smooth muscle tone (3). Studies on the use of alpha-blockers following transurethral resection of the prostate (TURP) have shown limited postoperative benefits (4). However, to the best of our knowledge, no study has specifically evaluated their use following HoLEP, an enucleation-based technique. Therefore, further studies are needed to assess the role of alpha-blockers in managing dysuria after HoLEP.\n\nThe aim of this study is to evaluate the effectiveness of alpha-blocker therapy in managing dysuria and other irritative symptoms following HoLEP. Additionally, the study seeks to determine the impact of this treatment on quality of life and patient satisfaction.",[141],"Prostate Hyperplasia","2025-03-19",{"date":144,"type":37},"2025-03-24",{"date":146,"type":37},"2025-03-04",{"date":148,"type":20},"2026-03-04",{"name":43,"class":44},""]